EdemSAgamahMD

Clinical Trials

• Decitabine in Treating Patients With Myelofibrosis Start of enrollment: 2004 Sep 29

  Active, not recruiting

  Phase 2

• Eribulin Mesylate in Treating Patients With Locally Advanced or Metastatic Cancer of the Urothelium and Kidney Dysfunction Start of enrollment: 2006 Oct 23

  Active, not recruiting

  Phase 1, Phase 2

• Cixutumumab and Doxorubicin Hydrochloride in Treating Patients With Unresectable, Locally Advanced, or Metastatic Soft Tissue Sarcoma Start of enrollment: 2008 Jun 01

  Completed

  Phase 1

• IMC-A12 With Mitotane vs Mitotane Alone in Recurrent, Metastatic, or Primary ACC That Cannot Be Removed by Surgery Start of enrollment: 2008 Dec 01

  Terminated

  Phase 2

• Dasatinib in Treating Patients With Recurrent or Metastatic Malignant Salivary Gland Tumors Start of enrollment: 2009 Mar 16

  Completed

  Phase 2

• Irinotecan Hydrochloride With or Without Alvocidib in Treating Patients With Advanced Stomach or Gastroesophageal Junction Cancer That Cannot Be Removed By Surgery Start of enrollment: 2009 Sep 01

  Completed

  Phase 2

• Cixutumumab and Sorafenib Tosylate in Treating Patients With Advanced Liver Cancer Start of enrollment: 2009 Aug 01

  Completed

  Phase 1

• Gemcitabine Hydrochloride With or Without Vismodegib in Treating Patients With Recurrent or Metastatic Pancreatic Cancer Start of enrollment: 2009 Sep 01

  Completed

  Phase 1, Phase 2

• Lenalidomide and Temsirolimus in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma or Non-Hodgkin Lymphoma Start of enrollment: 2010 Apr 15

  Completed

  Phase 1, Phase 2

• Entinostat and Anastrozole in Treating Postmenopausal Women With TNBC That Can Be Removed by Surgery Start of enrollment: 2010 Oct 01

  Terminated

  Phase 2

• MK2206 in Treating Patients With Advanced Liver Cancer That Did Not Respond to Previous Therapy Start of enrollment: 2010 Dec 01

  Terminated

  Phase 2

• Temsirolimus With or Without Cetuximab in Patients With Recurrent and/or Metastatic Head and Neck Cancer Who Did Not Respond to Previous Therapy Start of enrollment: 2010 Nov 01

  Completed

  Phase 2

• Cediranib Maleate With or Without Dasatinib in Patients With HRPC-Resistant to Treatment With Docetaxel Start of enrollment: 2010 Oct 01

  Completed

  Phase 2

• Saracatinib in Treating Patients With Prostate Cancer Start of enrollment: 2010 Dec 01

  Terminated

  Phase 2

• Veliparib With or Without Radiation Therapy, Carboplatin, and Paclitaxel in Patients With Stage III Non-small Cell Lung Cancer That Cannot Be Removed by Surgery Start of enrollment: 2011 Jun 20

  Active, not recruiting

  Phase 1, Phase 2

• Join now to see all